The NEDD9 expression does not influence RFS (AUC = 0.51, p = 0.35; Supplementary Figure S2D) or pCR response to endocrine therapy in ER+ breast cancers (AUC = 0.505, p = 0.47; Supplementary Figure S2C,D). This evidence concerns the gene NEDD9 and breast carcinoma.